Vaginal Bromocriptine for Treatment of Adenomyosis: Impact on Magnetic Resonance Imaging and Transvaginal Ultrasound

Johanna Andersson, Raffaella Pozzi Mucelli, E. Epstein, Elizabeth A. Stewart, Kristina Gemzell‐Danielsson
In: Obstetrical & Gynecological Survey · 2023 · vol. 78(1) , pp. 32–33 · doi:10.1097/01.ogx.0000912608.55729.b1 · W4313453119
article OA: closed CC0
View on OpenAlex View at publisher

Abstract

(Abstracted from Eur J Obstet Gynecol Reprod Biol 2020;254:38–43) Adenomyosis is a common, benign uterine disease that causes heavy menstrual bleeding and pelvic pain. A diagnosis of adenomyosis traditionally required hysterectomy, but now can be made based on magnetic resonance imaging (MRI) or transvaginal ultrasound (TVU).

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK